A new health technology assessment group, Warwick Evidence has been set up at Warwick University with £2.6 million funding to carry out technology reviews for the UK’s National Institute of Health and Clinical Excellence (NICE).
The Warwick Evidence team, led by Aileen Clarke and Paul Sutcliffe from Warwick Medical School, is one of three new technology assessment teams across the UK. It brings together experts in clinical and cost-effectiveness reviewing, health economics and modelling. The multidisciplinary team will work across several departments at the university, supported by a senior team of clinical and methodological experts at both local and national level.
Acting Dean of Warwick Medical School, Martin Underwood, said, “We are absolutely delighted about Warwick Evidence. Assessing new technologies to make sure they provide value for money is a key function for NICE and for the National Health Service, the role that Warwick Evidence will play will be crucial in this.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.